Clinical and translational research plays a vital role in determining treatment plans at Houston Methodist and in bringing tomorrow's cures to our patients today. Explore the bridges between research and clinical care that have been built by our interdisciplinary faculty team and global network of collaborators.
Our Recent Publication in Blood by Qing Yi, MD, PhD
Qing Yi, MD, PhD and his team recently published a research study in Blood which discusses the potential of RARγ agonists in overcoming multiple myeloma drug resistance to carfilzomib therapy.
Houston Methodist Neal Cancer Center Welcomes Ming You, MD, PhD and Expands Chemoprevention Research Team
Ming You, MD, PhD joins the Houston Methodist Cancer Center research team bringing his expertise in the rapidly evolving field of cancer chemoprevention.
Nestor F. Esnaola, MD, MPH, MBA, FACS Establishes A Mathematical Model for Predicting Immunotherapy Efficacy
In his recent publication in Medicine, Nestor F. Esnaola, MD, MPH, MBA, FACS discusses a mathematical model that can predict clinical response to checkpoint inhibitor therapy in human solid tumors.
Jenny C. Chang, MD is one of the first to describe intrinsic chemo-resistance of tumor-initiating cells
More To Explore